Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Return on Sales (2019 - 2025)

Volitionrx's Return on Sales history spans 9 years, with the latest figure at 0.72% for Q4 2025.

  • For Q4 2025, Return on Sales fell 198.0% year-over-year to 0.72%; the TTM value through Dec 2025 reached 3.39%, up 362.0%, while the annual FY2025 figure was 0.11%, 12.0% down from the prior year.
  • Return on Sales reached 0.72% in Q4 2025 per VNRX's latest filing, up from 0.06% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 5.13% in Q4 2021 to a low of 59.99% in Q1 2023.
  • Average Return on Sales over 5 years is 12.25%, with a median of 0.32% recorded in 2021.
  • Peak YoY movement for Return on Sales: soared 1907835bps in 2021, then plummeted -6073bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 5.13% in 2021, then plummeted by -85bps to 0.79% in 2022, then crashed by -4654bps to 35.79% in 2023, then soared by 108bps to 2.69% in 2024, then tumbled by -73bps to 0.72% in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Return on Sales are 0.72% (Q4 2025), 0.06% (Q3 2025), and 0.07% (Q2 2025).